Background: Diabetic neuropathic cachexia is a rare and little understood variant of diabetic neuropathy. It predominantly affects men with type 2 diabetes mellitus in their sixth to seventh decades of life and is characterized by the subacute onset of a painful sensory neuropathy, rapid weight loss, and psychiatric comorbidity.
Methods: We present the only female pediatric case described to date, and one of only a handful of cases reported to affect type 1 diabetics.
Results: In this patient a diagnosis of diabetic neuropathic cachexia was based on the rapid onset of severe allodynic pain, polyneuropathy, and marked weight loss in the setting of poorly controlled diabetes, without evidence of end-organ disease and exclusion of other known causes of neuropathy.
Conclusions: Diabetic neuropathic cachexia is a complex neuroendocrinologic disorder characterized by profound weight loss, neuropathic pain, and mood disturbance. Electrodiagnostic abnormalities were pronounced showing a moderately severe generalized sensorimotor polyneuropathy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pediatrneurol.2013.04.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Peripheral, central, and chemotherapy-induced neuropathic changes in pancreatic cancer.
Trends Neurosci
December 2024
State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, PR China. Electronic address:
In pancreatic cancer, significant alterations occur in the local nervous system, including axonogenesis, neural remodeling, perineural invasion, and perineural neuritis. Pancreatic cancer can impact the central nervous system (CNS) through cancer cell-intrinsic factors or systemic factors, particularly in the context of cancer cachexia. These peripheral and central neuropathic changes exert substantial influence on cancer initiation and progression.
View Article and Find Full Text PDFSupportive care of female hormones in brain health: what and how?
Front Pharmacol
July 2024
Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Article Synopsis
- Female hormones, particularly progesterone, are being recognized for roles beyond menopausal hormone therapy, including treating postpartum depression and managing appetite in cancer patients.
- The FDA has approved medications like brexanolone and zuranolone that leverage these hormones for rapid depression treatment and addressing weight loss, particularly in patients with advanced cancer.
- While these off-label uses show promise for mental health and pain relief, there are concerns about the risks and effectiveness that need careful consideration by patients and healthcare providers.
Palliative Medicine Fellows' Discussions, Perceptions, and Training Regarding Medical Cannabis.
J Pain Symptom Manage
June 2024
Tufts Medical Center, Tufts University School of Medicine (M.K.B.), Boston, Massachusetts, USA.
Context: Medical cannabis is increasingly considered for palliation of pain, nausea/vomiting, anorexia, and other symptoms.
Objectives: We aimed to determine whether training in hospice and palliative medicine (HPM) adequately prepares fellows to counsel patients about medical cannabis.
Methods: A previously validated questionnaire was adapted for HPM fellows.
The connection between innervation and metabolic rearrangements in pancreatic cancer through serine.
Front Oncol
December 2022
Department of Hepatobiliary and Pancreatic Surgery, Second Hospital of Jilin University, Changchun, China.
Pancreatic cancer is a kind of aggressive tumor famous for its lethality and intractability, and pancreatic ductal adenocarcinoma is the most common type. Patients with pancreatic cancer often suffer a rapid loss of weight and abdominal neuropathic pain in their early stages and then go through cachexia in the advanced stage. These features of patients are considered to be related to metabolic reprogramming of pancreatic cancer and abundant nerve innervation responsible for the pain.
View Article and Find Full Text PDFA Case Report of a Rare Debilitating Complication of Diabetes: Neuropathic Cachexia.
Cureus
September 2022
Internal Medicine, Indiana University Health Ball Memorial Hospital, Muncie, USA.
A 56-year-old male with a history of type 2 diabetes mellitus and hypertension presented with complaints of intractable burning paresthesia of bilateral extremities, hyperesthesia, and unintentional weight loss. Other symptoms included anorexia, orthostatic hypotension, bowel and bladder dysfunction, and painful burning sensation on the soles of the feet. Emotional lability and a melancholy mood were noted.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!